Home
Live Updates
Guselkumab Continues Winning Streak in Crohns Disease : comparemela.com
Guselkumab Continues Winning Streak in Crohn's Disease
Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials
Related Keywords
Fort Pierce ,
Florida ,
United States ,
Houston ,
Texas ,
Washington ,
Ed Susman ,
Md Anderson Cancer Center ,
Johnson ,
Disease Week ,
Cancer Center ,
Disease Activity Index ,
Stool Frequency ,
Abdominal Pain ,
comparemela.com © 2020. All Rights Reserved.